DRUG DOSE ADJUSTMENT IN CHRONIC KIDNEY FAILURE PATIENTS AT HOSPITAL X
Article Sidebar
Main Article Content
Abstract
Chronic Kidney Disease (CKD) is a significant global health issue, with increasing incidence rates, high treatment costs, and poor prognosis. Adjusting drug dosages in patients with CKD is essential to prevent worsening conditions and ensure proper therapy. This study examines the drug adjustment practices at Hospital X. This research method uses a descriptive research uses secondary data from medical records (Jan-Dec 2021) of CKD patients at Hospital X. Data include patient demographics, comorbidities, medications, and dosage adjustments according to the Renal Pharmacotherapy Handbook. Results: Among the 52 patients, the majority were female (60%) and aged 46-65 years (57%). Ranitidine was the most prescribed drug (47.37%) for CKD patients, with 56.76% dosages aligning with renal dosing guidelines. This study concluded that ranitidine was the most common medication, and over half of the prescriptions were aligned with the renal dosing guidelines.
Keywords: drug dose adjustment, chronic kidney failure, renal pharmacotherapy
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright Notice
 The author whose manuscript was published agreed to the following provisions:
- The publication right of all journal material published / released on the E-Journal website of the Medical Science Journal: The Pharmaceutical Scientific Journal is held by the editorial board with the author's knowledge (the moral rights remain the manuscript's author).
- Formal legal provisions for access to digital articles in electronic journals are subject to Creative Commons Attribution-ShareAlike (CC BY-SA) license terms, which means Medical Science Journal: Pharmaceutical Scientific Journal has the right to store, transfer media / format, manage in the form of database (database), maintain, and publish articles without asking permission from the author as long as they include the author's name as the copyright owner.
- Manuscripts that are published / released in print and electronically are open access for educational, research and library purposes. In addition to these objectives, the editorial board is not responsible for violations of copyright law.
Â
 
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.